| | | | | | | | | | | | | | | | |
| | |
 | Issue Date FY: 2024 ( Subtotal = $64,426,552 ) (Continued on the next page) |
| | 2024 | 2024 | UNIVERSITY OF CONNECTICUT HEALTH CENTER | 263 FARMINGTON AVE | FARMINGTON | CT | 06030-0001 | CAPITOL | USA | R01AG068860 | Reciprocal Modulation of the Microbiome and Cellular Senescence in Metabolic Dysfunction | 000 | 4 | NIH | 10/30/2023 | $42,531 |
| | 2024 | 2024 | UNIVERSITY OF CONNECTICUT HEALTH CENTER | 263 FARMINGTON AVE | FARMINGTON | CT | 06030-0001 | CAPITOL | USA | R21NS139034 | Molecular Mechanisms and Heterogeneity in the Inferior Olivary Nucleus Development | 000 | 1 | NIH | 7/5/2024 | $457,875 |
| | 2024 | 2024 | UNIVERSITY OF CONNECTICUT HEALTH CENTER | 263 FARMINGTON AVE | FARMINGTON | CT | 06030-0001 | CAPITOL | USA | R01AG080647 | Longitudinal Associations of Electroconvulsive Therapy with Neuropsychiatric Symptoms, Geriatric Syndromes, and Nursing Home Admission and Mortality Rates among Adults with Dementia | 001 | 2 | NIH | 6/6/2024 | $319,875 |
| | 2024 | 2024 | UNIVERSITY OF CONNECTICUT HEALTH CENTER | 263 FARMINGTON AVE | FARMINGTON | CT | 06030-0001 | CAPITOL | USA | R01NS133112 | Meningeal ectopic lymphoid tissues (mELTs): Composition, organization and expression revealed by imaging and in situ transcriptomics | 000 | 1 | NIH | 4/15/2024 | $462,960 |
| | 2024 | 2024 | UNIVERSITY OF CONNECTICUT HEALTH CENTER | 263 FARMINGTON AVE | FARMINGTON | CT | 06030-0001 | CAPITOL | USA | UH3DE028520 | Individualized Assessment and Treatment Program for TMD: Coping as a Mechanism | 000 | 6 | NIH | 7/2/2024 | $300,000 |
| | 2024 | 2024 | UNIVERSITY OF CONNECTICUT HEALTH CENTER | 263 FARMINGTON AVE | FARMINGTON | CT | 06030-0001 | CAPITOL | USA | T90DE033006 | Skeletal, Craniofacial and Oral Biology Training Grant | 000 | 2 | NIH | 6/27/2024 | $501,302 |
| | 2024 | 2024 | UNIVERSITY OF CONNECTICUT HEALTH CENTER | 263 FARMINGTON AVE | FARMINGTON | CT | 06030-0001 | CAPITOL | USA | F31AI178967 | Innate immune roles of glycoRNA | 001 | 1 | NIH | 7/15/2024 | $0 |
| | 2024 | 2024 | UNIVERSITY OF CONNECTICUT HEALTH CENTER | 263 FARMINGTON AVE | FARMINGTON | CT | 06030-0001 | CAPITOL | USA | F31AI178967 | Innate immune roles of glycoRNA | 000 | 1 | NIH | 7/15/2024 | $45,122 |
| | 2024 | 2024 | UNIVERSITY OF CONNECTICUT HEALTH CENTER | 263 FARMINGTON AVE | FARMINGTON | CT | 06030-0001 | CAPITOL | USA | R01HL171486 | Calcium Signaling Mechanisms in Cardiac Fibrogenesis | 000 | 1 | NIH | 6/1/2024 | $680,831 |
| | 2024 | 2024 | UNIVERSITY OF CONNECTICUT HEALTH CENTER | 263 FARMINGTON AVE | FARMINGTON | CT | 06030-0001 | CAPITOL | USA | R01AR084264 | Signaling mechanisms utilized by myostatin and related ligands in skeletal muscle | 000 | 1 | NIH | 3/22/2024 | $785,937 |
| | 2024 | 2024 | UNIVERSITY OF CONNECTICUT HEALTH CENTER | 263 FARMINGTON AVE | FARMINGTON | CT | 06030-0001 | CAPITOL | USA | R01AI167886 | Bacterial Reprogramming that Contributes to Antibiotic Persistence toward Topoisomerase Inhibitors | 000 | 1 | NIH | 5/21/2024 | $429,511 |
| | 2024 | 2024 | UNIVERSITY OF CONNECTICUT HEALTH CENTER | 263 FARMINGTON AVE | FARMINGTON | CT | 06030-0001 | CAPITOL | USA | R01AI167886 | Bacterial Reprogramming that Contributes to Antibiotic Persistence toward Topoisomerase Inhibitors | 001 | 1 | NIH | 5/30/2024 | $47,748 |
| | 2024 | 2024 | UNIVERSITY OF CONNECTICUT HEALTH CENTER | 263 FARMINGTON AVE | FARMINGTON | CT | 06030-0001 | CAPITOL | USA | R01CA282775 | How RNA binding proteins control effector T cell responses | 000 | 1 | NIH | 3/8/2024 | $474,189 |
| | 2024 | 2024 | UNIVERSITY OF CONNECTICUT HEALTH CENTER | 263 FARMINGTON AVE | FARMINGTON | CT | 06030-0001 | CAPITOL | USA | R21HD108696 | Mechanisms by Which Macrocephaly Underlies Autism Spectrum Disorder | 000 | 2 | NIH | 8/28/2024 | $208,125 |
| | 2024 | 2024 | UNIVERSITY OF CONNECTICUT HEALTH CENTER | 263 FARMINGTON AVE | FARMINGTON | CT | 06030-0001 | CAPITOL | USA | R18HS029639 | Adaptation of an Evidence-Based Curriculum to Teach the Prevention, Evaluation and Treatment of Maternal Medical Emergencies for Pre-hospital & Hospital Healthcare Workers in Rural Context | 001 | 2 | AHRQ | 5/22/2024 | $372,783 |
| | 2024 | 2024 | UNIVERSITY OF CONNECTICUT HEALTH CENTER | 263 FARMINGTON AVE | FARMINGTON | CT | 06030-0001 | CAPITOL | USA | R01AA030678 | Do peers enhance or detract progress in group MI? A look into emerging adult brain and behavior | 001 | 2 | NIH | 9/4/2024 | $437,516 |
| | 2024 | 2024 | UNIVERSITY OF CONNECTICUT HEALTH CENTER | 263 FARMINGTON AVE | FARMINGTON | CT | 06030-0001 | CAPITOL | USA | R21AI173921 | Elucidating the contributions of c-di-GMP and PlzA to tick- and mammalian host-adaptation in Lyme disease spirochetes | 000 | 2 | NIH | 5/8/2024 | $208,073 |
| | 2024 | 2024 | UNIVERSITY OF CONNECTICUT HEALTH CENTER | 263 FARMINGTON AVE | FARMINGTON | CT | 06030-0001 | CAPITOL | USA | R21AG078972 | Epidemiology and Clinical Outcomes of Electroconvulsive Therapy Use in Nursing Home Residents with Dementia | 001 | 2 | NIH | 6/28/2024 | $15,636 |
| | 2024 | 2024 | UNIVERSITY OF CONNECTICUT HEALTH CENTER | 263 FARMINGTON AVE | FARMINGTON | CT | 06030-0001 | CAPITOL | USA | R21AG078972 | Epidemiology and Clinical Outcomes of Electroconvulsive Therapy Use in Nursing Home Residents with Dementia | 000 | 2 | NIH | 2/21/2024 | $140,718 |
| | 2024 | 2024 | UNIVERSITY OF CONNECTICUT HEALTH CENTER | 263 FARMINGTON AVE | FARMINGTON | CT | 06030-0001 | CAPITOL | USA | R01AG083100 | Increasing successful returns to community living from nursing facilities through the Money Follows the Person program: Mechanisms for reducing disparities for older adults with dementia | 000 | 2 | NIH | 6/24/2024 | $778,409 |
| | 2024 | 2024 | UNIVERSITY OF CONNECTICUT HEALTH CENTER | 263 FARMINGTON AVE | FARMINGTON | CT | 06030-0001 | CAPITOL | USA | F31DK136259 | Investigating metabolism and DNA damage repair in uropathogenic Escherichia coli fluoroquinolone persisters | 000 | 2 | NIH | 8/29/2024 | $44,715 |
| | 2024 | 2024 | UNIVERSITY OF CONNECTICUT HEALTH CENTER | 263 FARMINGTON AVE | FARMINGTON | CT | 06030-0001 | CAPITOL | USA | R24GM150793 | Biological Magnetic Resonance Data Bank | 000 | 2 | NIH | 8/19/2024 | $747,399 |
| | 2024 | 2024 | UNIVERSITY OF CONNECTICUT HEALTH CENTER | 263 FARMINGTON AVE | FARMINGTON | CT | 06030-0001 | CAPITOL | USA | R01DE013986 | Oral Epithelial Cells, Candida and PMN Activation | 000 | 20 | NIH | 7/23/2024 | $507,193 |
| | 2024 | 2024 | UNIVERSITY OF CONNECTICUT HEALTH CENTER | 263 FARMINGTON AVE | FARMINGTON | CT | 06030-0001 | CAPITOL | USA | R21EY035976 | Targeting Corneal Schwann cells to counteract against toxin injury | 000 | 1 | NIH | 5/29/2024 | $208,073 |
| | 2024 | 2024 | UNIVERSITY OF CONNECTICUT HEALTH CENTER | 263 FARMINGTON AVE | FARMINGTON | CT | 06030-0001 | CAPITOL | USA | R01CA262430 | Control of regulatory T cells by IL-17 in colorectal cancer | 000 | 4 | NIH | 5/7/2024 | $356,393 |
| | 2024 | 2024 | UNIVERSITY OF CONNECTICUT HEALTH CENTER | 263 FARMINGTON AVE | FARMINGTON | CT | 06030-0001 | CAPITOL | USA | R00AA028048 | C-Type Lectins and Immune Surveillance in ALD | 000 | 5 | NIH | 7/26/2024 | $235,762 |
| | 2024 | 2024 | UNIVERSITY OF CONNECTICUT HEALTH CENTER | 263 FARMINGTON AVE | FARMINGTON | CT | 06030-0001 | CAPITOL | USA | R01AI021747 | Genetics of HSV DNA Replication | 001 | 38 | NIH | 5/16/2024 | $78,929 |
| | 2024 | 2024 | UNIVERSITY OF CONNECTICUT HEALTH CENTER | 263 FARMINGTON AVE | FARMINGTON | CT | 06030-0001 | CAPITOL | USA | F30AG081092 | Investigating the Role of p21-Highly Expressing Senescent Cells in Alzheimer's Dementia | 000 | 2 | NIH | 5/3/2024 | $45,187 |
| | 2024 | 2024 | UNIVERSITY OF CONNECTICUT HEALTH CENTER | 263 FARMINGTON AVE | FARMINGTON | CT | 06030-0001 | CAPITOL | USA | R21NS138991 | Electrical Signaling in Dendritic Branches | 000 | 1 | NIH | 7/5/2024 | $457,875 |
| | 2024 | 2024 | UNIVERSITY OF CONNECTICUT HEALTH CENTER | 263 FARMINGTON AVE | FARMINGTON | CT | 06030-0001 | CAPITOL | USA | U54AG075941 | The KAPP-Sen Tissue Mapping Center Collaborative | 001 | 4 | NIH | 8/27/2024 | $2,700,000 |
| | 2024 | 2024 | UNIVERSITY OF CONNECTICUT HEALTH CENTER | 263 FARMINGTON AVE | FARMINGTON | CT | 06030-0001 | CAPITOL | USA | R01AI021747 | Genetics of HSV DNA Replication | 000 | 38 | NIH | 12/6/2023 | $710,355 |
| | 2024 | 2024 | UNIVERSITY OF CONNECTICUT HEALTH CENTER | 263 FARMINGTON AVE | FARMINGTON | CT | 06030-0001 | CAPITOL | USA | F30NS129238 | The role of microglia as antigen presenting cells in Globoid Cell Leukodystrophy | 000 | 3 | NIH | 6/3/2024 | $53,974 |
| | 2024 | 2024 | UNIVERSITY OF CONNECTICUT HEALTH CENTER | 263 FARMINGTON AVE | FARMINGTON | CT | 06030-0001 | CAPITOL | USA | R01AI173305 | Impact of Senolytics on Aged Vaccine Responses | 000 | 2 | NIH | 10/30/2023 | $373,875 |
| | 2024 | 2024 | UNIVERSITY OF CONNECTICUT HEALTH CENTER | 263 FARMINGTON AVE | FARMINGTON | CT | 06030-0001 | CAPITOL | USA | R33AI154642 | Self-Powered Sample Concentrating and CRISPR-based Biosensing for Moile HIV-1 RNA Detection | 001 | 5 | NIH | 8/7/2024 | $25,000 |
| | 2024 | 2024 | UNIVERSITY OF CONNECTICUT HEALTH CENTER | 263 FARMINGTON AVE | FARMINGTON | CT | 06030-0001 | CAPITOL | USA | R33AI154642 | Self-Powered Sample Concentrating and CRISPR-based Biosensing for Moile HIV-1 RNA Detection | 001 | 5 | NIH | 8/7/2024 | $774,475 |
| | 2024 | 2024 | UNIVERSITY OF CONNECTICUT HEALTH CENTER | 263 FARMINGTON AVE | FARMINGTON | CT | 06030-0001 | CAPITOL | USA | R01AI173305 | Impact of Senolytics on Aged Vaccine Responses | 001 | 2 | NIH | 5/13/2024 | $41,541 |
| | 2024 | 2024 | UNIVERSITY OF CONNECTICUT HEALTH CENTER | 263 FARMINGTON AVE | FARMINGTON | CT | 06030-0001 | CAPITOL | USA | U01DE028520 | Individualized Assessment and Treatment Program for TMD: Coping as a Mechanism | 001 | 5 | NIH | 4/11/2024 | $0 |
| | 2024 | 2024 | UNIVERSITY OF CONNECTICUT HEALTH CENTER | 263 FARMINGTON AVE | FARMINGTON | CT | 06030-0001 | CAPITOL | USA | R01AR080131 | The role of Dot1L activity in chondrogenic differentiation | 000 | 3 | NIH | 6/7/2024 | $459,422 |
| | 2024 | 2024 | UNIVERSITY OF CONNECTICUT HEALTH CENTER | 263 FARMINGTON AVE | FARMINGTON | CT | 06030-0001 | CAPITOL | USA | R01DK121805 | MiR-150 regulated adiose tissue B cells in obesity | 001 | 5 | NIH | 5/6/2024 | $24,600 |
| | 2024 | 2024 | UNIVERSITY OF CONNECTICUT HEALTH CENTER | 263 FARMINGTON AVE | FARMINGTON | CT | 06030-0001 | CAPITOL | USA | F31HD114435 | Elucidating the role of FBLL1 in ribosome function during neuronal differentiation | 000 | 1 | NIH | 7/26/2024 | $45,419 |
| | 2024 | 2024 | UNIVERSITY OF CONNECTICUT HEALTH CENTER | 263 FARMINGTON AVE | FARMINGTON | CT | 06030-0001 | CAPITOL | USA | F31HD114435 | Elucidating the role of FBLL1 in ribosome function during neuronal differentiation | 001 | 1 | NIH | 7/26/2024 | $0 |
| | 2024 | 2024 | UNIVERSITY OF CONNECTICUT HEALTH CENTER | 263 FARMINGTON AVE | FARMINGTON | CT | 06030-0001 | CAPITOL | USA | U01DE028520 | Individualized Assessment and Treatment Program for TMD: Coping as a Mechanism | 003 | 5 | NIH | 7/1/2024 | -$300,000 |
| | 2024 | 2024 | UNIVERSITY OF CONNECTICUT HEALTH CENTER | 263 FARMINGTON AVE | FARMINGTON | CT | 06030-0001 | CAPITOL | USA | U01DE028520 | Individualized Assessment and Treatment Program for TMD: Coping as a Mechanism | 002 | 5 | NIH | 6/13/2024 | $50,572 |
| | 2024 | 2024 | UNIVERSITY OF CONNECTICUT HEALTH CENTER | 263 FARMINGTON AVE | FARMINGTON | CT | 06030-0001 | CAPITOL | USA | R01DK121805 | MiR-150 regulated adiose tissue B cells in obesity | 000 | 5 | NIH | 2/26/2024 | $369,000 |
| | 2024 | 2024 | UNIVERSITY OF CONNECTICUT HEALTH CENTER | 263 FARMINGTON AVE | FARMINGTON | CT | 06030-0001 | CAPITOL | USA | U01DE028520 | Individualized Assessment and Treatment Program for TMD: Coping as a Mechanism | 000 | 5 | NIH | 2/1/2024 | $568,937 |
| | 2024 | 2024 | UNIVERSITY OF CONNECTICUT HEALTH CENTER | 263 FARMINGTON AVE | FARMINGTON | CT | 06030-0001 | CAPITOL | USA | 90DDUC0140 | University of Connecticut A. J. Pappanikou Center for Excellence in Developmental Disabilities, Education, Research, and Service | 00 | 2 | ACL | 6/26/2024 | $620,675 |
| | 2024 | 2024 | UNIVERSITY OF CONNECTICUT HEALTH CENTER | 263 FARMINGTON AVE | FARMINGTON | CT | 06030-0001 | CAPITOL | USA | H4B33384 | Poison Control Stabilization and Enhancement Program | 00 | 6 | HRSA | 8/21/2024 | $266,253 |
| | 2024 | 2024 | UNIVERSITY OF CONNECTICUT HEALTH CENTER | 263 FARMINGTON AVE | FARMINGTON | CT | 06030-0001 | CAPITOL | USA | R01NS117449 | Contributions of Endothelial RNA-binding Protein Dysregulation to Blood Brain Barrier Defects and Neurodegenerative Disease | 000 | 2 | NIH | 8/22/2024 | $544,285 |
| | 2024 | 2024 | UNIVERSITY OF CONNECTICUT HEALTH CENTER | 263 FARMINGTON AVE | FARMINGTON | CT | 06030-0001 | CAPITOL | USA | R01NS131661 | Transient Receptor Potential Melastatin 2 (TRPM2) in Ischemic Stroke | 000 | 1 | NIH | 11/30/2023 | $451,949 |
|
